Cayuga Venture Fund and Rand Capital SBIC back Rheonix
Rheonix has closed $14 million in debt and equity financing. The capital infusion will be used to expand the company's physical facility and launch its first commercial product. Existing investors Cayuga Venture Fund and Rand Capital SBIC led the round. Headquartered in Ithaca, NY, Rheonix is a provider of molecular testing solutions.
19 December 2013•3 mins read
